Shibeshih Mitiku Belachew
Shibeshih Mitiku Belachew
Adresse e-mail validée de
Citée par
Citée par
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
Postnatal NG2 proteoglycan–expressing progenitor cells are intrinsically multipotent and generate functional neurons
S Belachew, R Chittajallu, AA Aguirre, X Yuan, M Kirby, S Anderson, ...
The Journal of cell biology 161 (1), 169-186, 2003
Elongator controls the migration and differentiation of cortical neurons through acetylation of α-tubulin
C Creppe, L Malinouskaya, ML Volvert, M Gillard, P Close, O Malaise, ...
Cell 136 (3), 551-564, 2009
Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy
T Plavina, M Subramanyam, G Bloomgren, S Richman, A Pace, S Lee, ...
Annals of neurology 76 (6), 802-812, 2014
Neurotransmitters as early signals for central nervous system development
L Nguyen, JM Rigo, V Rocher, S Belachew, B Malgrange, B Rogister, ...
Cell and tissue research 305, 187-202, 2001
The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐and glycine‐gated currents
JM Rigo, G Hans, L Nguyen, V Rocher, S Belachew, B Malgrange, ...
British journal of pharmacology 136 (5), 659-672, 2002
Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled …
L Kappos, JS Wolinsky, G Giovannoni, DL Arnold, Q Wang, C Bernasconi, ...
JAMA neurology 77 (9), 1132-1140, 2020
NG2-expressing cells in the subventricular zone are type C–like cells and contribute to interneuron generation in the postnatal hippocampus
AA Aguirre, R Chittajallu, S Belachew, V Gallo
The Journal of cell biology 165 (4), 575-589, 2004
Proliferative generation of mammalian auditory hair cells in culture
B Malgrange, S Belachew, M Thiry, L Nguyen, B Rogister, ML Alvarez, ...
Mechanisms of development 112 (1-2), 79-88, 2002
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
H Butzkueven, L Kappos, F Pellegrini, M Trojano, H Wiendl, RN Patel, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1190-1197, 2014
Autocrine/paracrine activation of the GABAA receptor inhibits the proliferation of neurogenic polysialylated neural cell adhesion molecule-positive (PSA-NCAM+) precursor cells …
L Nguyen, B Malgrange, I Breuskin, L Bettendorff, G Moonen, S Belachew, ...
Journal of Neuroscience 23 (8), 3278-3294, 2003
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
C Elliott, S Belachew, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, ...
Brain 142 (9), 2787-2799, 2019
Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies
X Yuan, R Chittajallu, S Belachew, S Anderson, CJ McBain, V Gallo
Journal of neuroscience research 70 (4), 529-545, 2002
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
C Elliott, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, C Bernasconi, ...
Multiple Sclerosis Journal 25 (14), 1915-1925, 2019
Cell “circadian” cycle: new role for mammalian core clock genes
L Borgs, P Beukelaers, R Vandenbosch, S Belachew, L Nguyen, ...
Cell Cycle 8 (6), 832-837, 2009
Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease
R Brouns, V Thijs, F Eyskens, M Van den Broeck, S Belachew, ...
Stroke 41 (5), 863-868, 2010
Identification of Sox17 as a transcription factor that regulates oligodendrocyte development
J Sohn, JA Natale, LJ Chew, S Belachew, Y Cheng, A Aguirre, J Lytle, ...
Journal of Neuroscience 26 (38), 9722-9735, 2006
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
G Giovannoni, G Cutter, MP Sormani, S Belachew, R Hyde, H Koendgen, ...
Multiple sclerosis and related disorders 12, 70-78, 2017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20